Cargando…

Single-Dose Gadobutrol in Comparison With Single-Dose Gadobenate Dimeglumine for Magnetic Resonance Imaging of Chronic Myocardial Infarction at 3 T

OBJECTIVES: The aim of this study was to compare the contrast-to-noise ratio (CNR) values of infarct and remote myocardium as well as infarct and blood after application of 0.1 mmol/kg gadobutrol and 0.1 mmol/kg gadobenate dimeglumine on late gadolinium enhancement magnetic resonance (MR) images. MA...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wildgruber, Moritz, Stadlbauer, Thomas, Rasper, Michael, Hapfelmeier, Alexander, Zelger, Otto, Eckstein, Hans-Henning, Halle, Martin, Rummeny, Ernst J., Huber, Armin M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Lippincott Williams & Wilkins 2014
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4196783/ https://www.ncbi.nlm.nih.gov/pubmed/24872002 http://dx.doi.org/10.1097/RLI.0000000000000076

Ejemplares similares

Single dose gadobenate dimeglumine for imaging chronic of myocardial infarction in comparison to double dose gadopentetate dimeglumine
por: Bauner, Kerstin U, et al.
Publicado: (2009)

Severe Adverse Drug Reaction to Gadobenate Dimeglumine
por: Singer, Benjamin D., et al.
Publicado: (2009)

Comparison of Gadopentetate dimeglumine and Gadobenate dimeglumine in depiction of non-ischemic fibrosis in hypertrophic cardiomyopathy
por: Rudolph, Andre, et al.
Publicado: (2009)

The Unusual Suspect: Gadobenate-Dimeglumine Induced Kounis Syndrome
por: Choudhry, Faiza, et al.
Publicado: (2019)

Low-dose gadobenate dimeglumine-enhanced MRI of the kidney for the differential diagnosis of localized renal lesions
por: Schneider, Guenther, et al.
Publicado: (2015)

Dose‐Lowering in Contrast‐Enhanced MRI of the Central Nervous System: A Retrospective, Parallel‐Group Comparison Using Gadobenate Dimeglumine
por: DeLano, Mark C., et al.
Publicado: (2021)

Nebulized liposomal gadobenate dimeglumine contrast formulation for magnetic resonance imaging of larynx and trachea
por: Wei, Xiaohui, et al.
Publicado: (2011)

A Comparison between Gadofosveset Trisodium and Gadobenate Dimeglumine for Steady State MRA of the Thoracic Vasculature
por: Camren, G. Paul, et al.
Publicado: (2014)

MRI of colorectal cancer liver metastases: comparison of orally administered manganese with intravenously administered gadobenate dimeglumine
por: Brismar, Torkel B., et al.
Publicado: (2011)

Gadobenate dimeglumine (MultiHance) or gadoterat emeglumine (Dotarem) for brain tumour imaging? An intra-individual comparison
por: Vaneckova, M, et al.
Publicado: (2015)

Small Brain Lesion Enhancement and Gadolinium Deposition in the Rat Brain: Comparison Between Gadopiclenol and Gadobenate Dimeglumine
por: Violas, Xavier, et al.
Publicado: (2022)

Gadobenate Dimeglumine as an Intrabiliary Contrast Agent: Comparison with Mangafodipir Trisodium with Respect to Non-dilated Biliary Tree Depiction
por: Lim, Joon Seok, et al.
Publicado: (2005)

Myocardial T1 mapping and determination of partition coefficients at 3 tesla: comparison between gadobenate dimeglumine and gadofosveset trisodium
por: Nacif, Marcelo Souto, et al.
Publicado: (2018)

Diagnostic value of gadobenate dimeglumine-enhanced hepatocyte-phase magnetic resonance imaging in evaluating hepatic fibrosis and hepatitis
por: Li, Xiu-Mei, et al.
Publicado: (2017)

Hepatobiliary phase hypointensity on gadobenate dimeglumine-enhanced magnetic resonance imaging may improve the diagnosis of hepatocellular carcinoma
por: Li, Yueming, et al.
Publicado: (2021)

Half-Dose versus Single-Dose Gadobutrol for Extracellular Volume Measurements in Cardiac Magnetic Resonance
por: Doeblin, Patrick, et al.
Publicado: (2023)

Use of oral gadobenate dimeglumine to visualise the oesophagus during magnetic resonance angiography in patients with atrial fibrillation prior to catheter ablation
por: Faletti, Riccardo, et al.
Publicado: (2014)

Compensatory biliary and urinary excretion of gadobenate ion after administration of gadobenate dimeglumine (MultiHance(®)) in cases of impaired hepatic or renal function: a mechanism that may aid in the prevention of nephrogenic systemic fibrosis?
por: Kirchin, M A, et al.
Publicado: (2015)

(18) F-FDG PET/MR imaging in patients with suspected liver lesions: Value of liver-specific contrast agent Gadobenate dimeglumine
por: Kirchner, Julian, et al.
Publicado: (2017)

Effect of Imaging Time in the Magnetic Resonance Detection of Intracerebral Metastases Using Single Dose Gadobutrol
por: Jeon, Ji-Young, et al.
Publicado: (2014)

Hypointense Hepatic Lesions Depicted on Gadobenate Dimeglumine-Enhanced Three-Hour Delayed Hepatobiliary-Phase MR Imaging: Differentiation between Benignancy and Malignancy
por: Hwang, Hye Sun, et al.
Publicado: (2009)

Imaging Findings of Hepatic Ewing’s Sarcoma on Computed Tomography and Gadobenate Dimeglumine-enhanced Magnetic Resonance Imaging: A Case Report and Literature Review
por: Lu, Tao, et al.
Publicado: (2022)

A Comparison of Low-Dose and Normal-Dose Gadobutrol in MR Renography and Renal Angiography
por: Bayrak, Ilkay Koray, et al.
Publicado: (2008)

Gadoxetic Acid (Gd-EOB-DTPA)-Enhanced MRI versus Gadobenate Dimeglumine (Gd-BOPTA)-Enhanced MRI for Preoperatively Detecting Hepatocellular Carcinoma: an Initial Experience
por: Park, Yulri, et al.
Publicado: (2010)

Diagnostic Efficacy and Safety of Gadoxetate Disodium vs Gadobenate Dimeglumine in Patients With Known or Suspected Focal Liver Lesions: Results of a Clinical Phase III Study
por: Zech, Christoph J, et al.
Publicado: (2019)

Preoperative radiomics model using gadobenate dimeglumine-enhanced magnetic resonance imaging for predicting β-catenin mutation in patients with hepatocellular carcinoma: A retrospective study
por: Zeng, Fengxia, et al.
Publicado: (2022)

High-throughput gadobutrol-enhanced CMR: a time and dose optimization study
por: D’Angelo, Tommaso, et al.
Publicado: (2017)

Ultra Low Dose CT Pulmonary Angiography with Iterative Reconstruction
por: Sauter, Andreas, et al.
Publicado: (2016)

Detection of Malignant Primary Hepatic Neoplasms with Gadobenate Dimeglumine (Gd-BOPTA) Enhanced T1-Weighted Hepatocyte Phase MR Imaging: Results of Off-site Blinded Review in a Phase-II Multicenter Trial
por: Peña, Constantino S., et al.
Publicado: (2001)

Breast lesion detection and characterization with contrast‐enhanced magnetic resonance imaging: Prospective randomized intraindividual comparison of gadoterate meglumine (0.15 mmol/kg) and gadobenate dimeglumine (0.075 mmol/kg) at 3T
por: Clauser, Paola, et al.
Publicado: (2018)

Gadobutrol: Fatal anaphylaxis: case report
Publicado: (2021)

Neurotoxic Manifestations of an Overdose Intrathecal Injection of Gadopentetate Dimeglumine
por: Park, Kwan-Woong, et al.
Publicado: (2010)

Gadobutrol in Renally Impaired Patients: Results of the GRIP Study
por: Michaely, Henrik J., et al.
Publicado: (2017)

Gadobutrol in India—A Comprehensive Review of Safety and Efficacy
por: Endrikat, Jan, et al.
Publicado: (2017)

Gadobutrol: A Review in Contrast-Enhanced MRI and MRA
por: Scott, Lesley J.
Publicado: (2018)

Safety and Efficacy of Gadobutrol-Enhanced MRI in Patients Aged Under 2 Years—A Single-Center, Observational Study
por: Bhargava, Ravi, et al.
Publicado: (2013)

Multispectral optoacoustic tomography of myocardial infarction
por: Taruttis, Adrian, et al.
Publicado: (2012)

Gadobutrol versus gadofosveset-trisodium in MR venography of the lower extremities
por: Arnoldussen, Carsten W. K. P., et al.
Publicado: (2017)

Dynamic CT Perfusion Imaging of the Myocardium: A Technical Note on Improvement of Image Quality
por: Muenzel, Daniela, et al.
Publicado: (2013)

Different Capacity of Monocyte Subsets to Phagocytose Iron-Oxide Nanoparticles
por: Settles, Marcus, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_of0vc2pg6oe77krvf55s7ro9jp